O'Shaughnessy Joyce,...,Cvetanovic Ana S,...,Stamatovic Ljiljana (2025) Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients With HER2-Positive Early Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II Study, CLINICAL BREAST CANCER, vol. 25, br. 6, str. - (Article) 

Geyer Jr Charles E,...,Stamatovic Ljiljana,...,(broj koautora 34) (2025) Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer, NEW ENGLAND JOURNAL OF MEDICINE, vol. 392, br. 3, str. 249-257 (Article) 

Geyer Jr Charles E,...,Stamatovic Ljiljana,...,(broj koautora 35) (2025) Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer, NEW ENGLAND JOURNAL OF MEDICINE, vol. , br. , str. - (Article; Early Access) 

O'Shaughnessy Joyce,...,Cvetanovic Ana S,...,Stamatovic Ljiljana (2021) Original Research Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study, EUROPEAN JOURNAL OF CANCER, vol. 152, br. , str. 223-232 (Article) 

Belkacemi Yazid,...,Tesanovic Dusanka D,...,Popovic Lazar S,...,Kovcin Vladimir N,...,Dzodic Radan R,Markovic Ivan Z,Vasovic Suzana,Stamatovic Ljiljana,Radosavljevic Davorin Z,Radulovic Sinisa S,...,(broj koautora 48) (2020) A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries, EUROPEAN JOURNAL OF CANCER, vol. 135, br. , str. 130-146 (Review) 

Conte Pier Franco,...,Stamatovic Ljiljana,...,(broj koautora 21) (2020) Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer, CANCER, vol. 126, br. 13, str. 3132-3139 (Article) 

Todorovic Vladimir,...,Babovic Nada Lj,...,Cetnikovic Bojana,Ceric Timur,...,Dzamic Zoran M,Dzodic Radan R,Eri Zivka,...,Knezevic-Usaj Slavica F,Kovcin Vladimir N,...,Markovic Ivan Z,Markovic Milan,Mijalkovic Nenad,...,Pantelic Aleksandra,Popovic Lazar S,Radosavljevic Davorin Z,...,Radulovic Sinisa S,...,Rosic Ivana,...,Stamatovic Ljiljana,...,Tesanovic Dusanka D,Tomasevic Zorica I,Tomasevic Zoran M,...,Vasovic Suzana,Vicko Ferenc,...,Zaric Bojan,...,(broj koautora 65) (2019) AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan), JOURNAL OF BUON, vol. 24, br. 5, str. 2180-2197 (Article) 

Stamatovic Ljiljana,Susnjar Snezana V,Gavrilovic Dusica,Minic Ivana Z,Ursulovic Tamara B,Dzodic Radan R (2018) The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients, JOURNAL OF BUON, vol. 23, br. 5, str. 1273-1280 (Article) 

Bosnjak Snezana M,Stamatovic Ljiljana,Borroni Maria Elisa,Rizzi Giada,Jordan Karin (2018) Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-Combination Antiemetic, in Patients With Gynecological Cancers Receiving Platinum-Based Chemotherapy, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol. 28, br. 6, str. 1153-1161 (Article) 

Krivokuca Ana M,Dragos Vita Setrajcic,Stamatovic Ljiljana,Blatnik Ana,Boljevic Ivana Z,Stegel Vida,Rakobradovic Jelena D,Skerl Petra,Jovandic Stevo,Krajc Mateja,Brankovic-Magic Mirjana V,Novakovic Srdjan (2018) Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin, FAMILIAL CANCER, vol. 17, br. 2, str. 179-185 (Article) 

Popovic Lazar S,Tomasevic Zorica I,Stamatovic Ljiljana,Markovic Ivan Z,Matovina-Brko Gorana G,Buta Marko N,Golubovic Andrija,Selakovic Vladimir,Trifunovic Jasna D,Mutrezani Zafir,Ivanovic Nebojsa S,Nedovic Jasmina R,Ninkovic Srdjan M,Filipovic Sladjana,Cvetanovic Ana S,Djordjevic Nebojsa P,Karanikolic Aleksandar D,Ivkovic-Kapicl Tatjana V,Vicko Ferenc (2018) Serbian consensus of neoadjuvant therapy for breast cancer: NeoPULSE, JOURNAL OF BUON, vol. 23, br. 2, str. 522-532 (Article) 

Stamatovic Ljiljana,Vasovic Suzana,Trifunovic Jasna D,Boskov Nedeljka,Gajic Z,Parezanovic A,Icevic M,Cirkovic Andja M,Milic Natasa M (2018) Factors influencing time to seeking medical advice and onset of treatment in women who are diagnosed with breast cancer in Serbia, PSYCHO-ONCOLOGY, vol. 27, br. 2, str. 576-582 (Article) 

Pljesa Igor,Berisavac Milica,Simic Tatjana P,Pekmezovic Tatjana D,Coric Vesna M,Suvakov Sonja R,Stamatovic Ljiljana,Matic Marija G,Gutic Bojana,Milenkovic Sanja M,Pljesa-Ercegovac Marija S,Savic-Radojevic Ana R (2017) Polymorphic expression of glutathione transferases A1, M1, P1 and T1 in epithelial ovarian cancer: a Serbian case-control study, JOURNAL OF BUON, vol. 22, br. 1, str. 72-79 (Article) 

Jassem Jacek,Ozmen Vahit,Bacanu Florin,Drobniene Monika,Eglitis Janis,Lakshmaiah Kuntegowdanahalli C,Kahan Zsuzsanna,Mardiak Jozef,Pienkowski Tadeusz,Semiglazova Tatiana,Stamatovic Ljiljana,Timcheva Constanta,Vasovic Suzana,Vrbanec Damir,Zaborek Piotr (2014) Delays in diagnosis and treatment of breast cancer: a multinational analysis, EUROPEAN JOURNAL OF PUBLIC HEALTH, vol. 24, br. 5, str. 761-767 (Article) 

Abu Rabi Zaki,Todorovic-Rakovic Natasa,Markicevic Milan A,Stamatovic Ljiljana,Vujasinovic Tijana,Nikolic-Vukosavljevic Dragica (2013) Change of influence of prognostic markers on metastasis free interval during and after adjuvant tamoxifen therapy in breast cancer patients, JOURNAL OF BUON, vol. 18, br. 2, str. 321-327 (Article) 

Konjevic Gordana M,Radenkovic Sandra S,Srdic Tatjana V,Jurisic Vladimir B,Stamatovic Ljiljana,Milovic Marijana M (2011) Association of decreased NK cell activity and IFN gamma expression with pSTAT dysregulation in breast cancer patients, JOURNAL OF BUON, vol. 16, br. 2, str. 219-226 (Article) 

Milovic-Kovacevic Marijana M,Stamatovic Ljiljana,Popov Ivan P,Radosevic-Jelic Ljiljana M,Kezic Iva (2010) Platinum - sensitive relapsed epithelial ovarian cancer: Not all the patients benefit from reinduction with carboplatin and paclitaxel, MEDICAL SCIENCE MONITOR, vol. 16, br. 11, str. CR549-CR554 (Article) 

Abu Rabi Zaki,Markicevic Milan A,Vujasinovic Tijana,Lukic Silvana T,Stamatovic Ljiljana,Nikolic-Vukosavljevic Dragica (2010) Early and Late Tamoxifen Resistance in Breast Cancer, ARCHIVES OF BIOLOGICAL SCIENCES, vol. 62, br. 2, str. 249-256 (Article) 

Tomasevic Zorica I,Jelic Svetislav B,Nikolic L,Filipovic I,Stamatovic Ljiljana,Radosavljevic Davorin Z (2003) Negative CEA values in metastatic colorectal carcinoma and the likelihood of complete chemotherapy response, INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, vol. 18, br. 1, str. 28-32 (Article) 

Jelic Svetislav B,Stamatovic Ljiljana,Vucicevic Slavko S,Petrovic Zeljko M,Kreacic Miroslav,Babovic Nada Lj,Jovanovic Natasa,Mikic Anton A,Gavrilovic Dusica (2002) Use of high-dose cytarabine to enhance cisplatin cytotoxicity - effects on the response and overall survival rates of advanced head and neck cancer patients, EUROPEAN JOURNAL OF CANCER, vol. 38, br. 11, str. 1478-1489 (Article) 

Jelic Svetislav B,Babovic Nada Lj,Stamatovic Ljiljana,Kreacic Miroslav,Matkovic Suzana V,Popov Ivan P (2001) Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures - A single-center study, MEDICAL ONCOLOGY, vol. 18, br. 3, str. 189-195 (Article) 

Susnjar Snezana V,Vasovic Suzana,Neskovic-Konstantinovic Zora B,Stamatovic Ljiljana,Lukic Vesna,Colakovic Slobodanka,Mitrovic LB,Jelic Svetislav B,Radulovic Sinisa S (1999) Mitoxantrone, 5-fluorouracil and low-dose leucovorin in doxorubicin-resistant advanced breast cancer patients: A phase II study, TUMORI, vol. 85, br. 6, str. 478-482 (Article)